Latest updates for Vedtx
Fresh curated links around VEDTX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- VTEB: Simple Municipal Bond Index ETF, Weak Investment Thesis, Better Choices Out There
- Vertical Data Inc. Begins Trading on the OTCQB Venture Market Under Ticker Symbol "VDTA"
- VBR: Leading Passive Small Value ETF
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Vertical Data Inc. Begins Trading on the OTCQB Venture Market Under Ticker Symbol "VDTA"
Public Markets Access Accelerates Capital Deployment for Vertical Data's AI Infrastructure Expansion
VTV: Vanguard's Passive $169B Value ETF Is Good, But SEIV's Active Approach May Be Better
Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top Holding
Artivion delivers advanced cardiovascular and vascular solutions to healthcare providers worldwide through its proprietary medical devices.
Vertex Pharmaceuticals Incorporated (VRTX) Q1 2026 Earnings Call Transcript
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Pennington Partners Bets Big on Broad Market With $5.4 Million VTHR Buy
The Vanguard Russell 3000 ETF offers investors a single-fund solution for diversified exposure to nearly the entire U.S. equity market through a low-cost, passively managed strateg...
Pennington Partners Bets Big on Broad Market With $5.4 Million VTHR Buy
The Vanguard Russell 3000 ETF offers investors a single-fund solution for diversified exposure to nearly the entire U.S. equity market through a low-cost, passively managed strateg...
Vaxcyte's Manufacturing-Backed Vaccine Platform Is Redefining The PCV Market
EVERTEC, Inc. 2026 Q1 - Results - Earnings Call Presentation
Vaxart anticipates early 2027 primary efficacy readout while aiming for Q2 sentinel data release
Truist Reiterates Buy Rating for Viridian Therapeutics (VRDN)
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
Viridian Therapeutics develops monoclonal antibody therapies targeting serious diseases, with a primary focus on thyroid eye disease.
1 No-Brainer Healthcare Vanguard ETF to Buy Right Now for Less Than $1,000
Healthcare stocks have been laggards for a while now. The current economic slowdown and structural tailwinds make it much more attractive now.
Definium Therapeutics, Inc. (DFTX) Analyst/Investor Day - Slideshow
VAT Group AG (VACNY) Q1 2026 Sales/Trading Call Transcript
Mar Vista U.S. Quality Strategy Exited Veralto Corporation (VLTO) for More Compelling Opportunities
The Best Vanguard ETF to Invest $1,000 in This April
With the markets looking very choppy so far in 2026, this sector has the tailwinds to keep moving higher.
Travere Therapeutics Inc. (TVTX): First-Mover Advantage Is Massive Moat
Large-cap IT stocks with A+ grade EPS revisions as earnings season begins
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.